Isabelle Metellus-Nanni
Marseille, 13916, France
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 16 publications
Retraction notice to "Molecular profile of androgen-independent prostate cancer xenograft LuCaP 23.1" [J. Steroid Biochem. Mol. Biol. 96 (2005) 355-365].
Journal: The Journal of steroid biochemistry and molecular biology
Published: September 04, 2026
Extreme Gradient Boosting Tuned with Metaheuristic Algorithms for Predicting Myeloid NGS Onco-Somatic Variant Pathogenicity.
Journal: Bioengineering (Basel, Switzerland)
Published: May 16, 2023
Plasma nanoDSF Denaturation Profile at Baseline Is Predictive of Glioblastoma EGFR Status.
Journal: Cancers
Published: October 09, 2022
Genomic analysis of paired IDHwt glioblastomas reveals recurrent alterations of MPDZ at relapse after radiotherapy and chemotherapy.
Journal: Journal of the neurological sciences
Published: October 01, 2021
Comparative genomic analysis of primary tumors and paired brain metastases in lung cancer patients by whole exome sequencing: a pilot study.
Journal: Oncotarget
Published: August 07, 2020
Multiplexed Droplet Digital PCR Assays for the Simultaneous Screening of Major Genetic Alterations in Tumors of the Central Nervous System.
Journal: Frontiers in oncology
Published: July 03, 2020
Detection of EGFR, KRAS and BRAF mutations in metastatic cells from cerebrospinal fluid.
Journal: Clinical chemistry and laboratory medicine
Published: June 15, 2017
Droplet digital PCR is a powerful technique to demonstrate frequent FGFR1 duplication in dysembryoplastic neuroepithelial tumors.
Journal: Oncotarget
Published: June 15, 2016
Somatic mosaicism underlies X-linked acrogigantism syndrome in sporadic male subjects.
Journal: Endocrine-related cancer
Published: March 01, 2016
Oncogenic drivers in daily practice improve overall survival in patients with lung adenocarcinoma
Journal: Revue des maladies respiratoires
Published: June 12, 2015
Evidence for BRAF V600E and H3F3A K27M double mutations in paediatric glial and glioneuronal tumours.
Journal: Neuropathology and applied neurobiology
Published: June 16, 2014
Differential expression of miR200a-3p and miR21 in grade II-III and grade IV gliomas: evidence that miR200a-3p is regulated by O⁶-methylguanine methyltransferase and promotes temozolomide responsiveness.
Journal: Cancer biology & therapy
Published: April 24, 2014
Last Updated: 09/26/2026